Lisata Therapeutics, Inc.
LSTANasdaqCIK 320017HealthcareFiscal year ends Dec 31
Reports and events: 390 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1910:38 ET | DEF 14A | Proxy statementPeriod 2026-11-09 | 0001140361-26-039986 |
| 2026-10-1420:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-039602 |
| 2026-09-1713:27 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036866 |
| 2026-08-0620:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000320017-26-000038 |
| 2026-08-0410:01 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-031028 |
| 2026-07-2416:15 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0001140361-26-029541 |
| 2026-07-1711:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-028763 |
| 2026-06-0911:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-024560 |
| 2026-06-0110:03 ET | 8-K | 8.01 Other events | 0001140361-26-023397 |
| 2026-05-2920:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-023336 |
| 2026-05-1120:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000320017-26-000032 |
| 2026-05-0410:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-018651 |
| 2026-04-2820:03 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0000320017-26-000028 |
| 2026-04-1520:01 ET | 8-K | 8.01 Other events | 0001140361-26-014775 |
| 2026-04-0300:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-013070 |
| 2026-03-1220:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000320017-26-000023 |
| 2026-03-0911:39 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-26-000020 |
| 2026-02-2721:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000320017-26-000012 |
| 2026-01-2713:27 ET | 8-K | 8.01 Other events | 0000320017-26-000008 |
| 2026-01-2113:58 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-26-000006 |
| 2025-11-0621:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000320017-25-000070 |
| 2025-11-0621:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000069 |
| 2025-10-1420:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000066 |
| 2025-10-0819:12 ET | 8-K | 1.01 Entry into a material agreement | 0000320017-25-000063 |
| 2025-08-0720:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000320017-25-000060 |
| 2025-08-0720:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000059 |
| 2025-07-1512:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-25-000048 |
| 2025-06-2612:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000043 |
| 2025-06-1713:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000039 |
| 2025-06-1320:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000320017-25-000037 |
| 2025-06-1020:03 ET | 8-K | 5.07 Shareholder vote results | 0000320017-25-000033 |
| 2025-05-0820:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000320017-25-000030 |
| 2025-05-0820:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000028 |
| 2025-04-2520:10 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0000320017-25-000023 |
| 2025-02-2721:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000320017-25-000011 |
| 2025-02-2721:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000010 |
| 2025-01-2321:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000004 |
| 2024-12-0313:33 ET | 8-K | 1.01 Entry into a material agreement | 0000320017-24-000061 |
| 2024-11-1221:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000320017-24-000058 |
| 2024-11-1221:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000057 |
| 2024-08-1220:21 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000320017-24-000051 |
| 2024-08-1220:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000049 |
| 2024-06-2720:53 ET | 8-K | 2.02 Results of operations | 0000320017-24-000034 |
| 2024-05-0920:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000320017-24-000031 |
| 2024-05-0920:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000029 |
| 2024-04-2920:51 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0000320017-24-000016 |
| 2024-04-1720:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000320017-24-000013 |
| 2024-02-2921:12 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000320017-24-000007 |
| 2024-02-2921:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000006 |
| 2023-11-0220:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000320017-23-000063 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.